SSC CGL 2019: Staff Selection Commission declares results for Tier 2 exam on ssc.nic.in

-

The Staff Selection Commission (SSC) announced the result of Combined Graduate Level Examination Tier-2 2019 on its official website on Friday. Applicants that had appeared in the SSC CGL Tier-2 exam 2019 can check their results on ssc.nic.in.

The CGL Tier-II computer-based examination 2019 was conducted from 15 November to 18 November 2020, while the CGL Tier-III, Descriptive Paper was held on 22 November 2020, which was conducted at various centres across the country.

Candidates who haven't qualified in Tier-II will not be eligible for evaluation of Tier-III (Descriptive Paper) and won't be considered for the further selection process.

Candidates have been shortlisted, category-wise, based on aggregate performance in Tier-I and Tier-II examination for evaluation of their Tier-III (Descriptive Paper).

Separate cut-offs have been fixed for the posts of Junior Statistical Officer (JSO), Assistant Audit Officer (AAO), and Statistical Investigator- Grade-II in list 1, list 2, and list 3.

Marks of the qualified/non-qualified candidates in the Tier-II exam will be uploaded on the website of the Commission along with the marks of the Tier-III exam after declaration of result of Tier-III (Descriptive Paper).

Commission short-listed the candidates for the next stage who have scored minimum marks in each paper of Tier-II. While the unreserved candidates need a minimum of 30 per cent, the cut-off is 25 per cent for OBC and EWS, and 20 per cent for others.

SSC CGL Tier-2 results have three lists that include the name of the candidate along with the code used for the category along with the roll number.

To check SSC CGL Tier-2 results:

Step 1: Go to the official website by typing ssc.nic.in

Step 2: Once the website is accessed go to the results section on the homepage and click on the link to check the results

Step 3: Users can see the SSC CGL Tier-2 results in a pdf format displayed on the screen

Step 4: Users can also download the results on the desktop and take a printout for future use



from Firstpost India Latest News https://ift.tt/3k7nthh
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more